175 related articles for article (PubMed ID: 29659895)
1. Identification of Differential Transcriptional Patterns in Primary and Secondary Hyperparathyroidism.
Sadowski SM; Pusztaszeri M; Brulhart-Meynet MC; Petrenko V; De Vito C; Sobel J; Delucinge-Vivier C; Kebebew E; Regazzi R; Philippe J; Triponez F; Dibner C
J Clin Endocrinol Metab; 2018 Jun; 103(6):2189-2198. PubMed ID: 29659895
[TBL] [Abstract][Full Text] [Related]
2. Reduced parathyroid vitamin D receptor messenger ribonucleic acid levels in primary and secondary hyperparathyroidism.
Carling T; Rastad J; Szabó E; Westin G; Akerström G
J Clin Endocrinol Metab; 2000 May; 85(5):2000-3. PubMed ID: 10843188
[TBL] [Abstract][Full Text] [Related]
3. A comparative study of the int-2 gene product in primary and secondary parathyroid lesions.
Tseleni-Balafouta S; Thomopoulou G; Lazaris ACh; Koutselini H; Davaris PS
Eur J Endocrinol; 2002 Jan; 146(1):57-60. PubMed ID: 11751068
[TBL] [Abstract][Full Text] [Related]
4. Parathyroid hormone immunohistochemistry in dogs with primary and secondary hyperparathyroidism: the question of adenoma and primary hyperplasia.
van Vonderen IK; Kooistra HS; Peeters ME; Rijnberk A; van den Ingh TS
J Comp Pathol; 2003 Jul; 129(1):61-9. PubMed ID: 12859909
[TBL] [Abstract][Full Text] [Related]
5. [The role of calcium sensitive and vitamin D receptors in the pathogenesis of sporadic multiple parathyroid gland disease].
Ilyicheva EA; Shurygina IA; Dremina NN; Bersenev GA; Grigoryev EG
Probl Endokrinol (Mosk); 2023 Jun; 69(3):24-34. PubMed ID: 37448244
[TBL] [Abstract][Full Text] [Related]
6. Aryl hydrocarbon receptor interacting protein (AIP) mutations occur rarely in sporadic parathyroid adenomas.
Pardi E; Marcocci C; Borsari S; Saponaro F; Torregrossa L; Tancredi M; Raspini B; Basolo F; Cetani F
J Clin Endocrinol Metab; 2013 Jul; 98(7):2800-10. PubMed ID: 23633209
[TBL] [Abstract][Full Text] [Related]
7. Reduced p18INK4c, p21CIP1/WAF1 and p27KIP1 mRNA levels in tumours of primary and secondary hyperparathyroidism.
Buchwald PC; Akerström G; Westin G
Clin Endocrinol (Oxf); 2004 Mar; 60(3):389-93. PubMed ID: 15009006
[TBL] [Abstract][Full Text] [Related]
8. Differential RNA expression profile by cDNA microarray in sporadic primary hyperparathyroidism (pHPT): primary parathyroid hyperplasia versus adenoma.
Velázquez-Fernández D; Laurell C; Saqui-Salces M; Pantoja JP; Candanedo-Gonzalez F; Reza-Albarrán A; Gamboa-Dominguez A; Herrera MF
World J Surg; 2006 May; 30(5):705-13. PubMed ID: 16680586
[TBL] [Abstract][Full Text] [Related]
9. [Study on the cellular proliferation and endocrine activity of the parathyroid gland in hyperparathyroidism].
Hosokawa S
Nihon Hinyokika Gakkai Zasshi; 1993 Aug; 84(8):1424-31. PubMed ID: 8411803
[TBL] [Abstract][Full Text] [Related]
10. Expression of transcripts encoding a parathyroid hormone-related peptide in abnormal human parathyroid tissues.
Ikeda K; Arnold A; Mangin M; Kinder B; Vydelingum NA; Brennan MF; Broadus AE
J Clin Endocrinol Metab; 1989 Dec; 69(6):1240-8. PubMed ID: 2573615
[TBL] [Abstract][Full Text] [Related]
11. Exclusive underexpression of vitamin D receptor exon 1f transcripts in tumors of primary hyperparathyroidism.
Correa P; Akerstrom G; Westin G
Eur J Endocrinol; 2002 Nov; 147(5):671-5. PubMed ID: 12444900
[TBL] [Abstract][Full Text] [Related]
12. Primary hyperparathyroidism: a current perspective.
DeLellis RA; Mazzaglia P; Mangray S
Arch Pathol Lab Med; 2008 Aug; 132(8):1251-62. PubMed ID: 18684024
[TBL] [Abstract][Full Text] [Related]
13. Parathyroid tumors and related disorders.
DeLellis RA
Mod Pathol; 2011 Apr; 24 Suppl 2():S78-93. PubMed ID: 21455204
[TBL] [Abstract][Full Text] [Related]
14. Identification of differentially expressed microRNA in parathyroid tumors.
Rahbari R; Holloway AK; He M; Khanafshar E; Clark OH; Kebebew E
Ann Surg Oncol; 2011 Apr; 18(4):1158-65. PubMed ID: 21086055
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of kinase genes in primary hyperparathyroidism: adenoma versus normal and hyperplastic parathyroid tissue.
Schachter PP; Ayesh S; Matouk I; Schneider T; Czerniak A; Hochberg A
Arch Pathol Lab Med; 2007 Jan; 131(1):126-30. PubMed ID: 17227113
[TBL] [Abstract][Full Text] [Related]
16. The histone methyltransferase EZH2, an oncogene common to benign and malignant parathyroid tumors.
Svedlund J; Barazeghi E; Stålberg P; Hellman P; Åkerström G; Björklund P; Westin G
Endocr Relat Cancer; 2014 Apr; 21(2):231-9. PubMed ID: 24292603
[TBL] [Abstract][Full Text] [Related]
17. Reduced immunostaining for the extracellular Ca2+-sensing receptor in primary and uremic secondary hyperparathyroidism.
Kifor O; Moore FD; Wang P; Goldstein M; Vassilev P; Kifor I; Hebert SC; Brown EM
J Clin Endocrinol Metab; 1996 Apr; 81(4):1598-606. PubMed ID: 8636374
[TBL] [Abstract][Full Text] [Related]
18. [Effect of calcium and magnesium on parathyroid hormone release from human parathyroid tissue in vitro].
Wagner PK; Krause U; Rothmund M
Res Exp Med (Berl); 1982; 181(3):205-10. PubMed ID: 7163647
[TBL] [Abstract][Full Text] [Related]
19. Calcium-sensing receptor and apoptosis in parathyroid hyperplasia of patients with secondary hyperparathyroidism.
Lee HJ; Seo UH; Kim WY; Woo SU; Lee JB
J Int Med Res; 2013 Feb; 41(1):97-105. PubMed ID: 23569134
[TBL] [Abstract][Full Text] [Related]
20. Co-expression of parathyroid hormone and chromogranin A in secondary hyperparathyroidism: a functional marker for secretory activity of hyperplastic nodules.
Tanaka R; Umemura S; Kakuta T; Fujisaki T; Sakai H; Saitoh A; Osamura RY
Pathol Res Pract; 2003; 199(2):93-9. PubMed ID: 12747471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
